Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.
Jie ZhangKevin HaynesAaron B MendelsohnJames MarshallCharles E BarrCara McDermottJeffrey BrownAnnemarie KlineJames KenneyKatelyn J KingCynthia HolmesKai YeungJohn BarronHuifeng YunCatherine M LockhartPublished in: Pharmacoepidemiology and drug safety (2019)
Medical claim NDC and HCPCS modifier improves identification of select biologics without product-specific HCPCS code, thereby facilitating product-specific biologic research.